A&M’s Healthcare Industry Group works for and with clinicians. A&M clinicians bridge the world of business with the clinical environment of a hospital or provider practice. They understand how providers think and act on what motivates them. A&M clinicians come from both surgical and medical specialties. They combined patient care with careers as hospital executives, managers, researchers and strategic policy advisors, and worked in the nation’s top tier medical systems. They lead value-based care efforts and play a role in any other project in need of clinical and operational performance improvement and enhanced efficiency.
A&M’s clinical services professionals provided pivotal advisory services to large organizations specific to the industry wide COVID-19 response, recovery and mitigation.
Rely on us for help with:
- Value Based Healthcare (Quality & Cost Optimization)
- Population Health
- Clinical Process Design, Integration and Standardization
- Care Model Transformation
- Physician Leadership and Governance
- Provider Alignment and Engagement
- Physician Productivity
- Bed Utilization and Efficiency
- Throughput Analysis
- Care Management / Discharge Planning
- Readmissions
- Cost of Care and Length of Stay Reduction
|
- Public Reporting of Quality and Indicators
- Service Line Rationalization
- Performance Monitoring, Trend Analyses and Improvement
- Patient Experience
- Nursing Services: Pharmacy, Supply Chain and Staffing/Productivity
- Clinical Ancillary
- Emergency Services Performance Improvement
- Surgical Service Assessment
- Clinical Thought Leadership
- COVID-19 Response and Recovery
- Interim Management
- Laboratory/Radiology Assessments and Efficiencies
|
Disruption in the ACA Market – Implications and Strategic Responses
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
The Effect of Trump’s Tariffs on the European Pharmaceutical and Biopharmaceutical Industry
June 9, 2025
As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could
be felt across the global healthcare landscape.
FORMER FEDERAL HEALTH MINISTER PROFESSOR GREG HUNT JOINS ALVAREZ & MARSAL AUSTRALIA
May 27, 2025
Alvarez & Marsal appoints The Honourable Greg Hunt as a Senior Advisor bolstering its Healthcare and Public Sector advisories in support of maximizing sustainable value for clients.
Contract Research Organisations M&A Market
March 28, 2025
Rising cost pressures, stricter regulatory demands and advancements in emerging therapeutics are intensifying competition within the industry. These dynamics are fuelling the demand for greater efficiency in development lifecycles, creating significant opportunities for outsourced providers like Contract Research Organisations (CROs).
